Volume 67, Issue 1 pp. 1-2

EDITORIAL

Vaccination against COVID-19 does not lead to exacerbation in patients with myasthenia gravis

Ari Breiner MD MSc FRCPC,

Corresponding Author

Ari Breiner MD MSc FRCPC

[email protected]

orcid.org/0000-0002-5225-3208

Department of Medicine (Neurology), The Ottawa Hospital, and Ottawa Hospital Research Institute, Ottawa, Canada

Eric Poulin Centre for Neuromuscular Disease, University of Ottawa, Ottawa, Canada

Correspondence

Ari Breiner, MD MSc FRCPC, The Ottawa Hospital, Civic Campus, 1053 Carling Ave., Room ES-08, Ottawa, Ontario, Canada K1Y 4E9.

Email: [email protected]

Contribution: Writing - original draft, Writing - review & editing

Search for more papers by this author

Pierre R. Bourque MD FRCPC,

Pierre R. Bourque MD FRCPC

orcid.org/0000-0002-7455-0254

Department of Medicine (Neurology), The Ottawa Hospital, and Ottawa Hospital Research Institute, Ottawa, Canada

Eric Poulin Centre for Neuromuscular Disease, University of Ottawa, Ottawa, Canada

Contribution: Writing - original draft, Writing - review & editing

Search for more papers by this author

Ari Breiner MD MSc FRCPC,

Corresponding Author

Ari Breiner MD MSc FRCPC

[email protected]

orcid.org/0000-0002-5225-3208

Department of Medicine (Neurology), The Ottawa Hospital, and Ottawa Hospital Research Institute, Ottawa, Canada

Eric Poulin Centre for Neuromuscular Disease, University of Ottawa, Ottawa, Canada

Correspondence

Ari Breiner, MD MSc FRCPC, The Ottawa Hospital, Civic Campus, 1053 Carling Ave., Room ES-08, Ottawa, Ontario, Canada K1Y 4E9.

Email: [email protected]

Contribution: Writing - original draft, Writing - review & editing

Search for more papers by this author

Pierre R. Bourque MD FRCPC,

Pierre R. Bourque MD FRCPC

orcid.org/0000-0002-7455-0254

Department of Medicine (Neurology), The Ottawa Hospital, and Ottawa Hospital Research Institute, Ottawa, Canada

Eric Poulin Centre for Neuromuscular Disease, University of Ottawa, Ottawa, Canada

Contribution: Writing - original draft, Writing - review & editing

Search for more papers by this author

First published: 02 November 2022

https://doi.org/10.1002/mus.27747

Share a link

Email
Wechat
Bluesky

Abstract

See article on pages 558-561 in volume 66, Issue 5, November issue.

CONFLICT OF INTEREST

AB reports grant funding from Muscular Dystrophy Canada. PB reports no relevant conflicts of interest.

Open Research

DATA AVAILABILITY STATEMENT

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

REFERENCES

1Gummi RR, Kukulka NA, Deroche CB, Govindarajan R. Factors associated with acute exacerbations of myasthenia gravis. Muscle Nerve. 2019; 60(6): 693-699.
10.1002/mus.26689
PubMed Web of Science® Google Scholar
2Sheikh S, Alvi U, Soliven B, Rezania K. Drugs that induce or cause deterioration of myasthenia gravis: an update. J Clin Med. 2021; 10(7):1334.
10.3390/jcm10071537
PubMed Web of Science® Google Scholar
3Martin Arias LH, Sanz R, Sainz M, Treceno C, Carvajal A. Guillain-Barre syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015; 33(31): 3773-3778.
10.1016/j.vaccine.2015.05.013
CAS PubMed Web of Science® Google Scholar
4Zinman L, Thoma J, Kwong JC, Kopp A, Stukel TA, Juurlink DN. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study. Muscle Nerve. 2009; 40(6): 947-951.
10.1002/mus.21440
CAS PubMed Web of Science® Google Scholar
5Chavez A, Pougnier C. A case of COVID-19 vaccine associated new diagnosis myasthenia gravis. J Prim Care Community Health. 2021; 12:21501327211051933.
10.1177/21501327211051933
Web of Science® Google Scholar
6Farina A, Falso S, Cornacchini S, et al. Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: a multicenter experience. Eur J Neurol. 2022; 29(8): 2505-2510.
10.1111/ene.15348
PubMed Web of Science® Google Scholar
7Ruan Z, Tang Y, Li C, et al. COVID-19 vaccination in patients with myasthenia gravis: a single-center case series. Vaccines (Basel). 2021; 9(10):1112.
10.3390/vaccines9101112
CAS PubMed Web of Science® Google Scholar
8Tagliaferri AR, Narvaneni S, Azzam MH, Grist W. A case of COVID-19 vaccine causing a myasthenia gravis crisis. Cureus. 2021; 13(6):e15581.
PubMed Web of Science® Google Scholar
9Watad A, De Marco G, Mahajna H, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021; 9(5):435.
10.3390/vaccines9050435
CAS PubMed Web of Science® Google Scholar
10Patone M, Handunnetthi L, Saatci D, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021; 27(12): 2144-2153.
10.1038/s41591-021-01556-7
CAS PubMed Web of Science® Google Scholar
11Urra Pincheira A, Alnajjar S, Katzberg H, et al. Retrospective study on the safety of COVID-19 vaccination in myasthenia gravis. Muscle Nerve. 2022; 66(5): 558-561.
10.1002/mus.27657
CAS PubMed Web of Science® Google Scholar
12Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021; 397(10269): 99-111.
10.1016/S0140-6736(20)32661-1
CAS PubMed Web of Science® Google Scholar

Volume67, Issue1

January 2023

Pages 1-2

Vaccination against COVID-19 does not lead to exacerbation in patients with myasthenia gravis

Abstract

CONFLICT OF INTEREST

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Vaccination against COVID-19 does not lead to exacerbation in patients with myasthenia gravis

Abstract

CONFLICT OF INTEREST

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

References

Related

Information